Early perfusion changes in multiple sclerosis patients as assessed by MRI using arterial spin labeling

Mar Jiménez de la Peña1, Ignacio Casanova Peña2, Pablo García-Polo García3

  • 1Department of Radiology, Hospital Universitario Quironsalud, Madrid, Spain.

Acta Radiologica Open
|February 1, 2020
PubMed
Abstract

Insights

Arterial spin labeling (ASL) detects early multiple sclerosis (MS) brain perfusion changes, even without structural differences. This non-invasive technique shows potential as a biomarker for monitoring MS patients.

Area of Science:

  • Neuroimaging
  • Neurology
  • Medical Research

Background:

  • Gadolinium-perfusion MRI reveals gray matter abnormalities in early multiple sclerosis (MS), preceding structural changes.
  • These perfusion alterations may correlate with cognitive deficits, particularly in working memory.
  • Arterial spin labeling (ASL) offers a non-invasive alternative for perfusion assessment, avoiding intravenous contrast agents.

Purpose of the Study:

  • To investigate perfusion changes in early MS patients, independent of cerebral volume alterations.
  • To evaluate the suitability of ASL as a non-invasive monitoring tool for MS.

Main Methods:

  • ASL MRI was used to measure cerebral blood flow and bolus arrival time in 28 MS patients and 19 healthy controls.
  • Neuropsychological tests (EDSS, SDMT) and volumetric MRI assessed clinical status and brain structure.
  • Spearman's correlation analysis examined relationships between clinical scores and perfusion parameters.

Main Results:

  • MS patients exhibited reduced cerebral blood flow and prolonged bolus arrival time compared to controls.
  • A negative correlation was observed between EDSS scores and thalamus transit time.
  • EDSS scores also correlated negatively with cerebral blood flow in the frontal cortex.

Conclusions:

  • ASL perfusion imaging can detect early changes in MS, even without evident structural volumetric differences.
  • Perfusion parameters show promise as potential biomarkers for monitoring disease progression in MS patients.
  • Further longitudinal studies are warranted to confirm the utility of ASL in MS management.